Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Metsera, Inc. - Common Stock
(NQ:
MTSR
)
83.18
+1.63 (+2.00%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,923,333
Open
81.50
Bid (Size)
88.00 (1,000)
Ask (Size)
92.50 (100)
Prev. Close
81.55
Today's Range
80.30 - 83.86
52wk Range
12.30 - 83.86
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Pfizer Clinches $10 Billion Deal To Buy Obesity Drug Maker Metsera, Outbidding Novo Nordisk In Fierce Battle For Weight-Loss Market Dominance
Today 1:56 EST
Nvidia CEO Jensen Huang cautioned Elon Musk against underestimating the challenges of semiconductor manufacturing, saying building a chip fab like TSMC's is "extremely hard."
Via
Benzinga
Deal Dispatch: From A Founder Comeback To Billion-Dollar Bids, This Week In M&A And Bankruptcy
November 07, 2025
Via
Benzinga
Performance
YTD
+213.9%
+213.9%
1 Month
+57.4%
+57.4%
3 Month
+173.6%
+173.6%
6 Month
+248.5%
+248.5%
1 Year
+213.9%
+213.9%
More News
Read More
The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things.
November 07, 2025
Via
Investor's Business Daily
Topics
Government
Pfizer To Raise Metsera Bid After Court Denies Attempt To Block Rival Deal
November 06, 2025
Via
Benzinga
Palantir, Hertz, Metsera, Uber, DraftKings: Stocks Making The Biggest Moves Today
November 04, 2025
Via
Stocktwits
Novo Nordisk Q3 Preview: Analysts See Profit Drop As Obesity Market Cools, Pfizer Tensions Rise
November 04, 2025
Via
Stocktwits
The Battle For Metsera Acquisition Heats Up As Pfizer Files A Second Lawsuit
November 03, 2025
Via
Stocktwits
Novo Nordisk Reportedly Refrains From Backing Down In Metsera Acquisition Battle, Sweetens Bid Further
November 06, 2025
Via
Stocktwits
'It's Getting Ugly,' Analyst Says As Pfizer Escalates Its Gloves-Off Fight For Metsera
November 06, 2025
Via
Investor's Business Daily
Novo Nordisk Snaps 11-Day Losing Streak After Court Rejects Pfizer’s Challenge To $10B Metsera Deal
November 05, 2025
Via
Stocktwits
Topics
Law Enforcement
Here's Why Shares in Viking Therapeutics Shot Higher in October
November 05, 2025
Via
The Motley Fool
Can Novo Nordisk’s ‘Attractive’ Fundamentals Outweigh Slowing Wegovy Sales And A $149 Price Cap?
November 05, 2025
Via
Stocktwits
Topics
Lawsuit
Novo, Pfizer Are Battling To Buy The Future Of Weight-Loss — But Viking Already Owns It
November 04, 2025
Via
Benzinga
Pfizer, Novo Nordisk Intensify Fight For Metsera As Buyout Offers Continue To Climb
November 04, 2025
Via
Benzinga
Novo Sweetens Its Bid For Metsera, Pledging Up To $10 Billion
November 04, 2025
Via
Investor's Business Daily
Metsera Gets Revised Bids From Pfizer, Novo Nordisk: Here’s Why It Matters
November 04, 2025
Via
Stocktwits
Pfizer Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
November 04, 2025
Via
Benzinga
Did Novo Nordisk Just Say "Checkmate" to Pfizer?
November 03, 2025
Via
The Motley Fool
Topics
Intellectual Property
Metsera Calls Pfizer's Claims 'Nonsense' In Latest Buyout Battle Salvo
November 03, 2025
Via
Investor's Business Daily
Topics
Economy
Lawsuit
Pfizer Accuses Novo Nordisk Of Antitrust Violations In Metsera Takeover Battle
November 03, 2025
Via
Benzinga
Topics
Lawsuit
Meet the 7% Yield Dividend Stock That Could Soar in 2026
November 03, 2025
Via
The Motley Fool
Topics
Intellectual Property
World Trade
Is It Time to Dump Your Shares of Pfizer?
November 02, 2025
Via
The Motley Fool
Topics
Intellectual Property
Pfizer Sues Novo Nordisk And Metsera To Block The Proposed $6.5 Billion Deal
October 31, 2025
Via
Investor's Business Daily
Topics
Law Enforcement
Lawsuit
Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise
October 31, 2025
Via
Stocktwits
10 Health Care Stocks Whale Activity In Today's Session
October 30, 2025
Via
Benzinga
Frequently Asked Questions
Is Metsera, Inc. - Common Stock publicly traded?
Yes, Metsera, Inc. - Common Stock is publicly traded.
What exchange does Metsera, Inc. - Common Stock trade on?
Metsera, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Metsera, Inc. - Common Stock?
The ticker symbol for Metsera, Inc. - Common Stock is MTSR on the Nasdaq Stock Market
What is the current price of Metsera, Inc. - Common Stock?
The current price of Metsera, Inc. - Common Stock is 83.18
When was Metsera, Inc. - Common Stock last traded?
The last trade of Metsera, Inc. - Common Stock was at 11/07/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.